These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Kidney function assessment in the critically ill child: is it time to leave creatinine behind? Goldstein SL. Crit Care; 2007; 11(3):141. PubMed ID: 17581273 [Abstract] [Full Text] [Related]
23. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Müller B. Crit Care; 2005 Feb; 9(1):R37-45. PubMed ID: 15693965 [Abstract] [Full Text] [Related]
28. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function. Nishikimi T, Mori Y, Ishimura K, Tadokoro K, Yagi H, Yabe A, Horinaka S, Matsuoka H. Am J Med; 2004 Apr 15; 116(8):517-23. PubMed ID: 15063812 [Abstract] [Full Text] [Related]
29. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S. Ren Fail; 2008 Apr 15; 30(6):625-8. PubMed ID: 18661413 [Abstract] [Full Text] [Related]
30. Serum cystatin C is a better marker of topotecan clearance than serum creatinine. Hoppe A, Séronie-Vivien S, Thomas F, Delord JP, Malard L, Canal P, Chatelut E. Clin Cancer Res; 2005 Apr 15; 11(8):3038-44. PubMed ID: 15837759 [Abstract] [Full Text] [Related]
32. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD. J Am Coll Cardiol; 2010 May 11; 55(19):2062-76. PubMed ID: 20447528 [Abstract] [Full Text] [Related]
35. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy. Rubattu S, Barbato A, Marchitti S, Iacone R, Di Castro S, Evangelista A, Stanzione R, Ippolito R, Sciarretta S, Palmieri L, Volpe M, Strazzullo P, Olivetti Heart Study Research Group. J Hypertens; 2010 Aug 11; 28(8):1638-45. PubMed ID: 20453667 [Abstract] [Full Text] [Related]
36. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. White C, Akbari A, Hussain N, Dinh L, Filler G, Lepage N, Knoll GA. J Am Soc Nephrol; 2005 Dec 11; 16(12):3763-70. PubMed ID: 16236805 [Abstract] [Full Text] [Related]
37. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Ren Fail; 2008 Dec 11; 30(2):181-6. PubMed ID: 18300118 [Abstract] [Full Text] [Related]
38. Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy. Mueller TF, Raeder J, Oettl K, Zitta S, Klausmann G, Estelberger W, Luyckx VA, Reibnegger G. Ren Fail; 2008 Dec 11; 30(1):21-9. PubMed ID: 18197539 [Abstract] [Full Text] [Related]
40. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease. Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M. Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]